{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:47:48Z","timestamp":1782755268787,"version":"3.54.5"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Georgia Research Alliance - Charles H. Wheatley Endowment"},{"DOI":"10.13039\/100012483","name":"University of Georgia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1RO1AI148365"],"award-info":[{"award-number":["1RO1AI148365"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Worldwide, recurrent vulvovaginal candidiasis (RVVC) is estimated to affect approximately 138 million women annually. Current treatments for RVVC include azole therapies; however, these frequently fail to prevent recurrence and are limited by potential teratogenic effects and increasing azole resistance. Despite these limitations, there are no approved fungal vaccines. While rodent models have advanced our understanding of disease pathogenesis and vaccine development, their variable susceptibility to human pathogens and limited ability to recapitulate human immune responses restrict translational progress. Here, we established a nonhuman primate model of VVC reinfection in Japanese macaques (\n                    <jats:italic>Macaca fuscata<\/jats:italic>\n                    ) and used this model to evaluate the immunogenicity and protective efficacy of the \u2018pan-fungal\u2019 vaccine candidate NXT-2. We show that like humans, Japanese macaques are susceptible to VVC infections with\n                    <jats:italic>C. albicans<\/jats:italic>\n                    and display evidence of active infection through the formation of hyphae and recruitment of polymorphonuclear cells within the vaginal lumen. Infection and reinfection induced limited anti-\n                    <jats:italic>Candida<\/jats:italic>\n                    IgG responses and did not prevent reinfection. Notably, immunization of\n                    <jats:italic>C. albicans<\/jats:italic>\n                    reinfected macaques with NXT-2 induced robust systemic and mucosal anti-NXT-2 IgG antibody titers and reduced fungal burden in the vaginal lumen following subsequent rechallenge. Together, these data establish a valuable preclinical model for investigating host responses to VVC reinfection and for vaccine development, highlighting the potential of NXT-2 as a vaccine candidate to prevent RVVC.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0352577","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:28:22Z","timestamp":1782754102000},"page":"e0352577","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunization with the pan-fungal vaccine, NXT-2a, reduces fungal burden following serial intravaginal challenges with C. albicans in a non-human primate model of experimental vulvovaginal candidiasis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5702-9662","authenticated-orcid":true,"given":"Daniel A.","family":"Wychrij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Rabacal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor I.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertine M.E.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1206-4147","authenticated-orcid":true,"given":"Casey Ellen","family":"Pac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-9465","authenticated-orcid":true,"given":"Kwadwo O.","family":"Oworae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3567-6261","authenticated-orcid":true,"given":"Karen A.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"6","key":"pone.0352577.ref001","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11908-010-0137-9","article-title":"Vulvovaginal candidiasis caused by non-albicans candida species: new insights","volume":"12","author":"MA Kennedy","year":"2010","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"pone.0352577.ref002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"JM Achkar","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"pone.0352577.ref003","article-title":"Vulvovaginal candidiasis: a current understanding and burning questions","volume":"6","author":"HME Willems","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"pone.0352577.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"KA Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"26","key":"pone.0352577.ref005","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJM199712253372607","article-title":"Vaginitis","volume":"337","author":"JD Sobel","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0352577.ref006","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review","volume":"18","author":"DW Denning","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pone.0352577.ref007","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/microorganisms8020144","article-title":"Recurrent vulvovaginal candidiasis: an immunological perspective","volume":"8","author":"D Rosati","year":"2020","journal-title":"Microorganisms"},{"issue":"7","key":"pone.0352577.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"DW Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"pone.0352577.ref009","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/714031126","article-title":"Distinct protective host defenses against oral and vaginal candidiasis","volume":"40","author":"PL Fidel","year":"2002","journal-title":"Med Mycol"},{"issue":"11","key":"pone.0352577.ref010","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of Direct Healthcare Costs of Fungal Diseases in the United States","volume":"68","author":"K Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0352577.ref011","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"PG Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"pone.0352577.ref012","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"EL Berkow","year":"2017","journal-title":"Infect Drug Resist"},{"key":"pone.0352577.ref013","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"SG Whaley","year":"2017","journal-title":"Front Microbiol"},{"issue":"7","key":"pone.0352577.ref014","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.180963","article-title":"Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies","volume":"191","author":"A B\u00e9rard","year":"2019","journal-title":"CMAJ"},{"key":"pone.0352577.ref015","article-title":"Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study","volume":"369","author":"Y Zhu","year":"2020","journal-title":"BMJ"},{"issue":"9","key":"pone.0352577.ref016","doi-asserted-by":"crossref","DOI":"10.1016\/j.annepidem.2017.08.010","article-title":"Recurrent vulvovaginal candidiasis","volume":"27","author":"F Blostein","year":"2017","journal-title":"Ann Epidemiol"},{"issue":"24","key":"pone.0352577.ref017","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/ajhp\/zxac256","article-title":"Ibrexafungerp: a new triterpenoid antifungal","volume":"79","author":"AJ Sucher","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"pone.0352577.ref018","doi-asserted-by":"crossref","first-page":"114091","DOI":"10.1016\/j.isci.2025.114091","article-title":"Advances in fungal vaccine development: progress in the face of emerging challenges","volume":"28","author":"M Moses","year":"2025","journal-title":"iScience"},{"issue":"30","key":"pone.0352577.ref019","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"F De Bernardis","year":"2012","journal-title":"Vaccine"},{"issue":"47","key":"pone.0352577.ref020","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1016\/j.vaccine.2013.09.016","article-title":"NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response","volume":"31","author":"AS Ibrahim","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"pone.0352577.ref021","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/pathogens4040697","article-title":"Studies of immune responses in candida vaginitis","volume":"4","author":"F De Bernardis","year":"2015","journal-title":"Pathogens"},{"key":"pone.0352577.ref022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/mmy\/myx139","article-title":"Candida vaginitis: virulence, host response and vaccine prospects","volume":"56","author":"F De Bernardis","year":"2018","journal-title":"Med Mycol"},{"issue":"52","key":"pone.0352577.ref023","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"CS Schmidt","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"pone.0352577.ref024","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal Immunotherapeutic Vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"JE Edwards","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0352577.ref025","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac248","article-title":"Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis","volume":"1","author":"E Rayens","year":"2022","journal-title":"PNAS Nexus"},{"key":"pone.0352577.ref026","doi-asserted-by":"crossref","first-page":"1729080","DOI":"10.3389\/fimmu.2025.1729080","article-title":"Protective efficacy of a \u201cpan-fungal\u201d vaccination strategy against experimental Pneumocystis infection in drug-immunosuppressed macaques","volume":"16","author":"W Rabacal","year":"2026","journal-title":"Front Immunol"},{"issue":"10","key":"pone.0352577.ref027","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/vaccines13101033","article-title":"Active and passive immunization of pan-fungal vaccine NXT-2 reduces morbidity and mortality in an immunosuppressed murine model of candida auris systemic infection","volume":"13","author":"KO Oworae","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"pone.0352577.ref028","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-025-01171-4","article-title":"Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model","volume":"10","author":"DA Wychrij","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"1","key":"pone.0352577.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000713","article-title":"Characterization of the oral fungal microbiome (mycobiome) in healthy individuals","volume":"6","author":"MA Ghannoum","year":"2010","journal-title":"PLoS Pathog"},{"issue":"1","key":"pone.0352577.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054379","article-title":"Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women","volume":"8","author":"T Drell","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"pone.0352577.ref031","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","article-title":"The gut mycobiome of the Human Microbiome Project healthy cohort","volume":"5","author":"AK Nash","year":"2017","journal-title":"Microbiome"},{"issue":"3","key":"pone.0352577.ref032","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1086\/314964","article-title":"Differential susceptibility of two species of macaques to experimental vaginal candidiasis","volume":"180","author":"C Steele","year":"1999","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0352577.ref033","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1128\/IAI.01544-15","article-title":"Experimental models of vaginal Candidiasis and their relevance to human Candidiasis","volume":"84","author":"A Cassone","year":"2016","journal-title":"Infect Immun"},{"key":"pone.0352577.ref034","doi-asserted-by":"crossref","DOI":"10.1177\/0192623308327415","article-title":"Summary comparison of female reproductive system in human and the cynomolgus monkey (Macaca fascicularis)","volume":"36","author":"E Van Esch","year":"2008","journal-title":"Toxicol Pathol"},{"issue":"2022","key":"pone.0352577.ref035","article-title":"Role of the human vaginal microbiota in the regulation of inflammation and sexually transmitted infection acquisition: Contribution of the non-human primate model to a better understanding?","volume":"4","author":"C Adapen","year":"2022","journal-title":"Front Reprod Health"},{"issue":"5","key":"pone.0352577.ref036","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.4049\/jimmunol.1700320","article-title":"Modified vaccinia virus Ankara vector induces specific cellular and humoral responses in the female reproductive tract, the main HIV portal of entry","volume":"199","author":"R Marlin","year":"2017","journal-title":"J Immunol"},{"key":"pone.0352577.ref037","doi-asserted-by":"crossref","first-page":"1536750","DOI":"10.3389\/fbioe.2025.1536750","article-title":"Non-human primate: the new frontier model of female reproductive engineering","volume":"13","author":"YY Kim","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"pone.0352577.ref038","article-title":"Nonhuman primate models for HIV\/AIDS vaccine development","volume":"102","author":"Y Sui","year":"2013","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"pone.0352577.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006141","article-title":"An HSV-2 trivalent vaccine is immunogenic in Rhesus macaques and highly efficacious in guinea pigs","volume":"13","author":"S Awasthi","year":"2017","journal-title":"PLoS Pathog"},{"issue":"12","key":"pone.0352577.ref040","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3390\/v14122819","article-title":"Recombinant simian varicella virus-simian immunodeficiency virus vaccine induces T and B cell functions and provides partial protection against repeated mucosal SIV challenges in Rhesus Macaques","volume":"14","author":"B Pahar","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"pone.0352577.ref041","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0300985815622974","article-title":"Contributions of nonhuman primates to research on aging","volume":"53","author":"ES Didier","year":"2016","journal-title":"Vet Pathol"},{"issue":"2","key":"pone.0352577.ref042","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/IAI.01417-13","article-title":"Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis","volume":"82","author":"BM Peters","year":"2014","journal-title":"Infect Immun"},{"issue":"5","key":"pone.0352577.ref043","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1128\/IAI.72.5.2939-2946.2004","article-title":"An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis","volume":"72","author":"PL Fidel","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"pone.0352577.ref044","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1073\/pnas.1012861108","article-title":"Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection","volume":"108","author":"Z Li","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0352577.ref045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001432-200302000-00008","article-title":"Immunology of the human genital tract","volume":"16","author":"M Johansson","year":"2003","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"pone.0352577.ref046","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/00362178385380341","article-title":"IgA and IgG serum antibodies to Candida albicans in women of child-bearing age","volume":"21","author":"H Sch\u00f8nheyder","year":"1983","journal-title":"Sabouraudia"},{"issue":"4","key":"pone.0352577.ref047","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1590\/S0104-42302003000400037","article-title":"IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis","volume":"49","author":"RJV de Carvalho","year":"2003","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"3","key":"pone.0352577.ref048","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/514097","article-title":"Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen","volume":"176","author":"PL Fidel","year":"1997","journal-title":"J Infect Dis"},{"key":"pone.0352577.ref049","doi-asserted-by":"crossref","first-page":"100185","DOI":"10.1016\/j.pvr.2019.100185","article-title":"Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature","volume":"8","author":"J Pattyn","year":"2019","journal-title":"Papillomavirus Res"},{"issue":"58","key":"pone.0352577.ref050","first-page":"3382","article-title":"Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis","author":"J Yano","year":"2011","journal-title":"J Vis Exp"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:28:29Z","timestamp":1782754109000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352577"}},"subtitle":[],"editor":[{"given":"Aijaz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0352577","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}